A congressional report on the specialty pharmacy linked to a deadly meningitis outbreak has faulted state and federal regulators for failing to address serious safety concerns at the New England Compounding Center in Massachusetts, according to the Wall Street Journal.
A report by bipartisan staff of the Senate Health, Education, Labor and Pensions Committee, which met Thursday to examine the issue, concluded that regulators knew of problems ...
continue reading...